Neurogene
NGNE
NGNE
44 hedge funds and large institutions have $46.1M invested in Neurogene in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 24
85% less capital invested
Capital invested by funds: $302M → $46.1M (-$255M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
44
Holding in Top 10
–
Calls
$2.53M
Puts
$2.83M
Top Buyers
| 1 | +$3.05M | |
| 2 | +$1.06M | |
| 3 | +$1.01M | |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$765K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$483K |
Top Sellers
| 1 | -$18.9M | |
| 2 | -$10.5M | |
| 3 | -$7.04M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.32M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$5.63M |